Search

everythinglearnresearchcommunity

for

Search:↓

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

A mother and daughter had severe skin, hair, and eye issues linked to IFAP.

A man developed a skin cancer called folliculotropic mycosis fungoides after a kidney transplant.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

Sunscreen particles were not found in inflamed or fibrotic areas of skin in FFA patients, suggesting no direct link to the disease.

Frontal fibrosing alopecia can affect men's beards and leads to permanent hair loss.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

Certain drugs can cause hair loss, but stopping the drug usually leads to hair regrowth.

Tofacitinib helped regrow hair in a teen with a unique pattern of alopecia areata.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

A 77-year-old woman with hair loss had high testosterone and 17OH-progesterone levels, but no significant findings on imaging.

Women with thyroid disease are more likely to experience female pattern hair loss, especially if they've had thyroid disease for a long time.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Trichofolliculoma has specific cytokeratin patterns that help in its diagnosis.

Alopecia areata is linked to thyroid diseases, and thyroid testing may help affected patients.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Hair transplant destroyed by lichen planopilaris.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Antimicrobial lotion reduces inflammation and increases hair density in hair loss patients.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Hair loss in males and females is influenced by immune cell interactions, with potential treatments identified.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Men with male pattern baldness have higher levels of A-FABP, which might help in early detection.

Immune cells around hair follicles help control hair growth and could be targets for treating hair disorders.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.